Field Trip Archives

StaffMay 4, 2021

Psychedelic clinic companies have been expanding quickly as more patients are seeking alternatives to traditional prescription drug treatments. Both Field Trip Health and Novamind announced news of their expanding clinics across the country. Field Trip Field Trip Health Ltd. (OTCQX: FTRPF) opened its fifth location in the United States in the city of Houston, TX. […]

StaffMarch 17, 2021

Field Trip Health Ltd. (OTCQX: FTRPF) closed the bought deal offering that brought the company a whopping $95 million. As a result, Field Trip issued 14,661,499 common shares, at a price of C$6.50 per Common Share, for aggregate gross proceeds of $95 million. The stock was lately trading at C$6.40. The deal was upsized from […]

Debra BorchardtOctober 29, 2020

Field Trip Health Ltd. (CSE: FTRP) (OTC: FTRPF) provided an update on its in-vivo and in-vitro studies on FT-104, its lead drug candidate. FT-104 is a novel, synthetic psychedelic molecule developed by Field Trip. The company confirmed both the successful GLP synthesis of FT-104 and that FT-104 is a serotonin 5HT2A receptor agonist (the serotonin […]

Debra BorchardtOctober 6, 2020

Field Trip Health Ltd. (CSE: FTRP) has become the latest psychedelic treatment company to go public through a reverse takeover of Newton Energy Corp. The company began trading today on the Canadian Securities Exchange under the symbol FTRP. Joseph del Moral, CEO of Field Trip, said, “Our public listing will increase our visibility among investors […]

Anne-Marie FischerNovember 12, 2019

“If cannabis has been significant, psilocybin will have much more of a therapeutic impact,” said Toronto-based cannabis-turned-psychedelics entrepreneur Ronan Levy, when Green Market Report caught up with him to talk about the future of research on psychedelics. Field Trip Ventures, the world’s first integrated company in legal psychedelics and psychedelic-assisted psychotherapy, announced last month that […]